Table 3 Distribution of comorbid diagnoses among ODD (+) and ODD (−) cases according to waves*
From: Prevalence and diagnostic stability of ADHD and ODD in Turkish children: a 4-year longitudinal study
1stwave | 2ndwave | 3rdwave | 4thwave | |||||
|---|---|---|---|---|---|---|---|---|
ODD (+) | ODD (−) | ODD (+) | ODD (−) | ODD (+) | ODD (−) | ODD (+) | ODD (−) | |
N = 23 | N = 63 | N = 14 | N = 69 | N = 15 | N = 71 | N = 11 | N = 70 | |
n-% | n-% | n-% | n-% | n-% | n-% | n-% | n-% | |
ADHD | 20–87.0% * | 20–31.7% * | 13–92.9% ** | 32–46.4% ** | 15–100% * | 30–42.3% * | 8–72.7% | 20–28.6% * |
Anxiety Disorders | 7–30.4% | 26–41.3% | 2–14.3% | 5–7.2% | -- | 2–2.8% | -- | 4–5.7% |
Mood Disorders | 2–8.7% | 6–9.5% | -- | 1–1.4% | 1-6.7% | 4–5.6% | -- | 3–4.3% |
Tic Disorders | 2–8.7% | 4–6.3% | 1–7.1% | 1–1.4% | -- | 1–1.4% | 1–9.1% | -- |
Enuresis | 3–13.0% | 12–19.0% | 2–14.3% | 6–8.7% | -- | 3–4.2% | -- | 2–2.9% |
Encopresis | 3–13.0% | 1–1.6% | -- | -- | -- | -- | -- | -- |